Genome editing and stem cells: Questions and Answers

The development of new precise and fast genome editing tools, like CRISPR/Cas9, has changed the landscape of biomedical research forever.  Much has been written about the technology, but what does it mean for the field of stem cell research and regenerative medicine? Take an in-depth look at genome editing and stem cells with our Questions and Answers.

Policy Briefing Relating to Regenerative Medicine and Reimbursement

Members of the ESRC-funded REGenableMED project have published a Policy Briefing which explores a number of key factors that are likely to determine the reimbursement of regenerative medicine therapies as they move towards the clinic. The Briefing outlines those factors that are specific to the UK as well as more widely, and concludes with a series of priorities that policy needs to address.

New UK report on opportunities and challenges of regenerative medicine

A new report looks at how UK institutions and agencies are 'readying' themselves for the opportunities and challenges of regenerative medicine. Produced by the ESRC-funded REGenableMED project, it covers key developments in the UK regenerative medicine policy sector, the challenges faced, and some of the responses to those challenges.

Managing the potential and pitfalls of emerging stem cell therapies

While blood stem cells have been used clinically for over 40 years, it was the discovery of human embryonic stem cells in 1998, that has built expectations for people affected by a multitude of degenerative, chronic and fatal diseases with no cures or effective treatments. The speed with which therapies were expected to roll out of the lab did not take into consideration the complete lack of infrastructure required to make it happen, for many turning potential into frustration.

Centre for Bionetworking organises international conference on ‘Global life science and bionetworking’

On November 11th and 12th, stem cell scientists, clinicians and social scientists from around the world gathered at the University of Sussex to discuss and debate current practices around stem cell research and therapy in an international conference organised by the Centre for Bionetworking, Department of Anthropology. Specifically, delegates sought to answer the central question of the conference: What is there between bona fide and rogue stem cell therapy?

ISSCR 2014: Awards for Public Service

We would like to offer our warmest congratulations to Paolo Bianco, MD, Sapienza University of RomeElena Cattaneo, PhD, University of Milan, and Michele De Luca, MD, University of Modena and Reggio Emilia, who received their ISSCR Public Service Award on the 18th of June at the ISSCR Annual Meeting in Vancouver. 

Nature commentaries tackle current issues in regulation of stem cell therapies

Two recent opinion pieces in Nature highlight important social, ethical and regulatory issues around stem cell research. 

Watch the European Parliament hearing on the "One of Us" Petition.

On the 16th of April, a hearing was held at the European Parliament to discuss a petition which seeks to ban all EU funding for research or development activities which involves the destruction of human embryos. A number of EuroStemCell partners attending the hearing. The European Commission has until the 28th of May to respond and we will keep you updated on the developments with this petition.

German survey highlights high public awareness of stem cells

A survey carried out on behalf of the Stem Cell Network of North Rhine Westphalia (KSNRW) has suggested an increase in support for stem cell research among the German public compared to levels identified in other surveys over the last five years. Interviews with over 1000 adults showed a high level of support for research on both tissue (adult) stem cells and embryonic stem cells.

Science at the Senate: workshops in Italy on Science, Innovation and Health

Andrea Grignolio is a historian of medicine, currently teaching History of Medicine at University of Rome “La Sapienza” and working in the Senate Office of stem cell biologist and senator, Elena Cattaneo. He has a keen interest in science communication and is currently working with Prof Cattaneo on a series of events that bring together scientists and politicians. He told us more about the effect this new events programme is already having in Italy.

Distribuir contenido